mangalore today
name
name
name
Friday, January 31
namenamename

 

Govt panel approves use of Corbevax for 5-12 year age group


Mangaloretoday.com

New Delhi, April 21, 2022: Expert panel of Drug Controller General of India (DCGI)-- India’s drug regulator-- has recommended granting emergency use authorisation for Biological E’s Covid-19 vaccine Corbevax for children in 5 to 12 years age group.

 

Corbevax


Developed by Hyderabad-based firm Biological-E, Corbevax is India’s first indigenously developed RBD protein sub-unit vaccine against Covid-19.

From March 16 this year, Corbevax is being given to children between the ages of 12 and 14 years.

Meanwhile, the government has sought more data from Bharat Biotech before granting approval for use of its Covid-19 vaccine, Covaxin, in children aged 5-12.


Courtesy: India Today


Write Comment | E-Mail To a Friend | Facebook | Twitter | Print
Error:NULL
Write your Comments on this Article
Your Name
Native Place / Place of Residence
Your E-mail
Your Comment
You have characters left.
Security Validation
Enter the characters in the image above